{ "company_number": "SC354920", "name": "Norsepharm Limited", "url": "/company/SC354920", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2009-02-11", "dissolved_on": null, "sic_codes": [ "47730" ], "registered_address": { "id": 1873672, "url": "/address/1873672", "line1": "43 43 VICTORIA STREET", "line2": "", "post_town": "KIRKWALL", "county": "ORKNEY ISLANDS", "country": "UNITED KINGDOM", "postcode": "KW15 1DN" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/SC354920", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-12-31", "last_made_up": "2025-03-31", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/SC354920/accounts/2025-03-31", "made_up_date": "2025-03-31", "period_start": "2025-03-31", "period_end": "2025-03-31", "entity_name": "Norsepharm Limited", "dormant": false, "average_employees": "10.00", "tangible_fixed_assets": "1253696.00", "debtors": "494580.00", "cash_bank_in_hand": "84946.00", "current_assets": "720904.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "222102.00", "total_assets_less_current_liabilities": "1475798.00", "net_assets_liabilities": "862228.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2025.zip" }, { "url": "/company/SC354920/accounts/2024-03-31", "made_up_date": "2024-03-31", "period_start": "2024-03-31", "period_end": "2024-03-31", "entity_name": "Norsepharm Limited", "dormant": false, "average_employees": "10.00", "tangible_fixed_assets": "1244442.00", "debtors": "263207.00", "cash_bank_in_hand": "151454.00", "current_assets": "566721.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-428472.00", "total_assets_less_current_liabilities": "815970.00", "net_assets_liabilities": "795027.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2024.zip" }, { "url": "/company/SC354920/accounts/2023-03-31", "made_up_date": "2023-03-31", "period_start": "2023-03-31", "period_end": "2023-03-31", "entity_name": "Norsepharm Limited", "dormant": false, "average_employees": "10.00", "tangible_fixed_assets": "568162.00", "debtors": "257644.00", "cash_bank_in_hand": "78419.00", "current_assets": "413969.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "156241.00", "total_assets_less_current_liabilities": "724403.00", "net_assets_liabilities": "708730.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2023.zip" }, { "url": "/company/SC354920/accounts/2022-03-31", "made_up_date": "2022-03-31", "period_start": "2022-03-31", "period_end": "2022-03-31", "entity_name": "Norsepharm Limited", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "590515.00", "debtors": "141014.00", "cash_bank_in_hand": "190079.00", "current_assets": "399311.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "134362.00", "total_assets_less_current_liabilities": "724877.00", "net_assets_liabilities": "706730.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2022.zip" }, { "url": "/company/SC354920/accounts/2021-03-31", "made_up_date": "2021-03-31", "period_start": "2021-03-31", "period_end": "2021-03-31", "entity_name": "Norsepharm Limited", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "607489.00", "debtors": "161976.00", "cash_bank_in_hand": "207634.00", "current_assets": "427262.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "90909.00", "total_assets_less_current_liabilities": "698398.00", "net_assets_liabilities": "677416.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2021.zip" }, { "url": "/company/SC354920/accounts/2020-03-31", "made_up_date": "2020-03-31", "period_start": "2020-03-31", "period_end": "2020-03-31", "entity_name": "Norsepharm Limited", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "590925.00", "debtors": "212501.00", "cash_bank_in_hand": "77459.00", "current_assets": "349218.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-59556.00", "total_assets_less_current_liabilities": "531369.00", "net_assets_liabilities": "514009.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2020.zip" }, { "url": "/company/SC354920/accounts/2019-03-31", "made_up_date": "2019-03-31", "period_start": "2019-03-31", "period_end": "2019-03-31", "entity_name": "Norsepharm Ltd", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "601974.00", "debtors": "187860.00", "cash_bank_in_hand": "59861.00", "current_assets": "307514.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-58571.00", "total_assets_less_current_liabilities": "543403.00", "net_assets_liabilities": "456301.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2019.zip" }, { "url": "/company/SC354920/accounts/2018-03-31", "made_up_date": "2018-03-31", "period_start": "2018-03-31", "period_end": "2018-03-31", "entity_name": "Norsepharm Ltd", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "515923.00", "debtors": "140359.00", "cash_bank_in_hand": "60466.00", "current_assets": "261230.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-70993.00", "total_assets_less_current_liabilities": "444930.00", "net_assets_liabilities": "355283.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2018.zip" }, { "url": "/company/SC354920/accounts/2017-03-31", "made_up_date": "2017-03-31", "period_start": "2017-03-31", "period_end": "2017-03-31", "entity_name": "Norsepharm Ltd", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "526308.00", "debtors": "173476.00", "cash_bank_in_hand": "55067.00", "current_assets": "286218.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-86997.00", "total_assets_less_current_liabilities": "439311.00", "net_assets_liabilities": "287354.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2017.zip" }, { "url": "/company/SC354920/accounts/2016-03-31", "made_up_date": "2016-03-31", "period_start": "2016-03-31", "period_end": "2016-03-31", "entity_name": "Norsepharm Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "534554.00", "debtors": "172546.00", "cash_bank_in_hand": "56061.00", "current_assets": "293593.00", "creditors_due_within_one_year": "210844.00", "creditors_due_after_one_year": "393477.00", "net_current_assets_liabilities": "82749.00", "total_assets_less_current_liabilities": "617303.00", "net_assets_liabilities": "223826.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "223825.00", "shareholder_funds": "223826.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2016.zip" }, { "url": "/company/SC354920/accounts/2015-03-31", "made_up_date": "2015-03-31", "period_start": "2015-03-31", "period_end": "2015-03-31", "entity_name": "Norsepharm Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "547784.00", "debtors": "123873.00", "cash_bank_in_hand": "33205.00", "current_assets": "223509.00", "creditors_due_within_one_year": "157739.00", "creditors_due_after_one_year": "470803.00", "net_current_assets_liabilities": "65770.00", "total_assets_less_current_liabilities": "613554.00", "net_assets_liabilities": "142751.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "142750.00", "shareholder_funds": "142751.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2015.zip" }, { "url": "/company/SC354920/accounts/2014-03-31", "made_up_date": "2014-03-31", "period_start": "2014-03-31", "period_end": "2014-03-31", "entity_name": "Norsepharm Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "562626.00", "debtors": "80635.00", "cash_bank_in_hand": "20158.00", "current_assets": "150004.00", "creditors_due_within_one_year": "117673.00", "creditors_due_after_one_year": "492647.00", "net_current_assets_liabilities": "32331.00", "total_assets_less_current_liabilities": "594957.00", "net_assets_liabilities": "102310.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "102309.00", "shareholder_funds": "102310.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2014.zip" }, { "url": "/company/SC354920/accounts/2013-03-31", "made_up_date": "2013-03-31", "period_start": "2013-03-31", "period_end": "2013-03-31", "entity_name": "Norsepharm Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "459197.00", "debtors": "73136.00", "cash_bank_in_hand": "18545.00", "current_assets": "137912.00", "creditors_due_within_one_year": "115357.00", "creditors_due_after_one_year": "447284.00", "net_current_assets_liabilities": "22555.00", "total_assets_less_current_liabilities": "481752.00", "net_assets_liabilities": "34468.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "34467.00", "shareholder_funds": "34468.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2013.zip" }, { "url": "/company/SC354920/accounts/2012-03-31", "made_up_date": "2012-03-31", "period_start": "2012-03-31", "period_end": "2012-03-31", "entity_name": "Norsepharm Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "107454.00", "debtors": "47023.00", "cash_bank_in_hand": "62564.00", "current_assets": "133319.00", "creditors_due_within_one_year": "75227.00", "creditors_due_after_one_year": "164520.00", "net_current_assets_liabilities": "58092.00", "total_assets_less_current_liabilities": "165546.00", "net_assets_liabilities": "1026.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "1025.00", "shareholder_funds": "1026.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2012.zip" }, { "url": "/company/SC354920/accounts/2011-03-31", "made_up_date": "2011-03-31", "period_start": "2011-03-31", "period_end": "2011-03-31", "entity_name": "Norsepharm Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "46706.00", "debtors": "18102.00", "cash_bank_in_hand": "18643.00", "current_assets": "49992.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "7800.00", "total_assets_less_current_liabilities": "54506.00", "net_assets_liabilities": "-36945.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "-36946.00", "shareholder_funds": "-36945.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2011.zip" }, { "url": "/company/SC354920/accounts/2010-02-28", "made_up_date": "2010-02-28", "period_start": "2010-02-28", "period_end": "2010-02-28", "entity_name": "Norsepharm Limited", "dormant": true, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": null, "total_assets_less_current_liabilities": null, "net_assets_liabilities": "1.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2010.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/SC354920/filing-history" }, "confirmation_statement": { "next_due": "2026-10-18", "last_made_up": "2025-10-04" }, "officers": [], "psc": [ { "name": "Ms Rebecca Jane May", "kind": "individual-person-with-significant-control", "person_url": "/person/4132536", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" }, { "name": "Mr Torquil Clyde", "kind": "individual-person-with-significant-control", "person_url": "/person/5071996", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent", "right-to-appoint-and-remove-directors", "right-to-appoint-and-remove-directors-as-firm" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "Scotland", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-02T07:01:15.144032+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }